RHON-KLINIKUM AG (0NQH) AI Stock Analysis
Top Page
RHON-KLINIKUM AG
(LSE:0NQH)
No summary available
RHON-KLINIKUM AG (0NQH) vs. iShares MSCI United Kingdom ETF (EWC)
- Market Cap
- EUR 963.91M
- Dividend Yield
- 1.44%
- Average Volume (3M)
- 615
- Price to Earnings (P/E)
- 22.5
- Beta (1Y)
- -0.23
- Revenue Growth
- 4.91%
- EPS Growth
- 11.71%
- Country
- UK
- Employees
- 19,120
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Care Facilities
RHON-KLINIKUM AG Business Overview & Revenue Model
Company Description
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, delivers extensive healthcare services across Germany, encompassing inpatient, day-patient, and outpatient treatment models. The company's hospitals provide a broad spectrum of medical...
RHON-KLINIKUM AG Peers Comparison
Overall Rating
DE:M1279Outperform
DE:FME72Outperform
DE:LIK67Neutral
DE:MED64Neutral
DE:MAK47Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 79Outperform | EUR 344.06M | 17.94 | 16.58% | 6.13% | -27.50% | 13.64% | |
| 72Outperform | EUR 10.73B | 12.17 | 7.21% | 3.69% | -0.47% | 48.60% | |
| 67Neutral | EUR 153.00M | 27.60 | 22.18% | 1.96% | 35.46% | 17.88% | |
| 64Neutral | EUR 251.75M | 8.72 | 11.54% | 0.75% | 2.94% | -14.28% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 47Neutral | EUR 18.98M | -1.39 | 16.80% | ― | 2.73% | -1.80% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GB:0NQH | RHON-KLINIKUM AG | 14.30 | 2.68 | 23.10% | |
| DE:FME | Fresenius Medical Care AG & Co. KGaA | 40.40 | -3.51 | -8.00% | |
| DE:MED | MEDICLIN AG | 5.30 | 1.68 | 46.37% | |
| DE:MAK | MATERNUS-Kliniken AG | 0.91 | -0.14 | -12.98% | |
| DE:LIK | Limes Schlosskliniken AG | 510.00 | 158.82 | 45.22% | |
| DE:M12 | M1 Kliniken AG | 19.56 | 5.41 | 38.19% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.